Tag Archives: ONCS

H.C. Wainwright Reiterates Their Buy Rating on OncoSec Medical (ONCS)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS) today and set a price target of $4. The company’s shares closed yesterday at $1.66. Selvaraju commented: “Our price target is derived from a market value

OncoSec Medical (ONCS) Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $4. The company’s shares closed on Friday at $1.61. Selvaraju wrote: “Our price target is derived

OncoSec Medical (ONCS) Initiated with a Buy at H.C. Wainwright

OncoSec Medical (NASDAQ: ONCS) received a Buy rating and a $4 price target from H.C. Wainwright analyst Ram Selvaraju today. The company’s shares closed yesterday at $1.51. Selvaraju observed: “Our price target is derived from a market value of $222M

H.C. Wainwright Keeps Their Buy Rating on OncoSec Medical

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $4. The company’s shares closed yesterday at $1.34. Selvaraju noted: “We note that Ms. O’Connor, know

OncoSec Medical Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS) today and set a price target of $4. The company’s shares closed yesterday at $1.47. Selvaraju observed: “We have adjusted our projections and we currently estimate

Thursday’s Midday Stock Update: SeaDrill LTD (SDRL), Halcon Resources (HK), OncoSec Medical (ONCS), Dynavax (DVAX), Ambarella (AMBA)

So far Thursday, May 17, NASDAQ is up 0.25% and the S&P is up 0.33%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; SeaDrill LTD (NYSE:SDRL), Halcon Resources (NYSE:HK), OncoSec Medical (NASDAQ:ONCS), Dynavax